FDA 483 - Patricia Kropf MD - October 21, 2020

An FDA inspection of Patricia Kropf MD, a clinical investigator in Philadelphia, revealed one significant observation. The firm failed to conduct an investigation in accordance with the investigational plan, specifically regarding the administration of study drug to a subject. Another observation was removed during discussions with management.